Bristol-Myers Squibb Co. (BMY) Reports In-Line Q1 EPS; Reaffirms

April 25, 2013 7:32 AM

Bristol-Myers Squibb Co. (NYSE: BMY) reported Q1 EPS of $0.41, in-line with the analyst estimate of $0.41. Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found